Scientists hunt for blood clues to make nut allergy treatment safer
NCT ID NCT06554691
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines blood samples from 90 children with peanut or tree nut allergies to find immune markers that show how well oral immunotherapy is working. Researchers compare kids receiving immunotherapy, those avoiding nuts, and healthy adults. The goal is to develop better ways to monitor treatment and personalize care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGY;FOOD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier de Luxembourg
Luxembourg, 1210, Luxembourg
-
Clinical and Epidemiological Investigation Center, Luxembourg Institute of Health
Luxembourg, 1210, Luxembourg
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A spoonful of nuts? trial tests Multi-Allergy desensitization in kids
- Could a Mother's diet during pregnancy prevent peanut and egg allergies in her baby?
- Are allergy pens long enough? study measures thigh depth to find out
- AI tool aims to cut allergy misdiagnosis in primary care
- Can allergy drugs help kids tolerate peanut and more?
- Fish allergy cure? new trial tests codfish therapy in kids